43
Growth Score
pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
2060963
Thea Pharma US markets prescription and OTC eye care, including IYUZEH for glaucoma and iVIZIA preservative-free dry eye and eyelid care.
About the Company
Thea Pharma US provides ophthalmic therapies and ocular surface care products. The portfolio includes IYUZEH (latanoprost ophthalmic solution 0.005%) for reducing intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Consumer offerings under the iVIZIA brand include preservative-free dry eye drops, eyelid cleansing
wipes, and contact lens care solutions. The company focuses on preservative-free formulations and multi-dose delivery systems suitable for sensitive eyes. Services include medical information for healthcare professionals and patient access support for prescribed treatments.
